Convenia Injectable Antibiotic for Pets (10 ml)
- Notice
- Description
- Directions
- Reviews
Notices
Must be shipped Express 1-2 Days A $29.95 flat rate fee is charged for all orders. Someone should be present to sign for and receive the order when it ships to you. For more shipping info click here.
Description
Convenia (cefovecin sodium) is an FDA-Approved, injectable antimicrobial indicated for the treatment of canine skin infections (secondary superficial pyoderma, abscesses, and wounds) caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G). It also is indicated in feline skin infections (wounds and abscesses) caused by susceptible strains of Pasteurella multocida.
Indications
Dogs
Convenia is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Cats
Convenia is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
Key Benefits
- Professionally administered injection provides an assured course of treatment—no missed or off-schedule doses, no interruption of treatment, no leftover pills.
- Reaches peak plasma levels quickly and has a distinctly long half-life.
- Provides sustained and uninterrupted therapeutic drug concentrations.
- Demonstrated efficacy in treating the most common skin infections in dogs and cats.1,2
- Gives owners peace of mind that their pets are receiving the treatment they need without the stress of administering daily oral medications.
- Aqueous, non-depot injection for rapid release.
NADA 141-285
Directions
View Convenia Injectable product label.
Dosage & Administration
Dogs
Convenia should be administered as a single subcutaneous injection of 3.6 mg/lb (8 mg/kg) body weight. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete. The decision for a second injection for any individual dog should take into consideration such factors as progress toward clinical resolution, the susceptibility of the causative organisms, and the integrity of the dog’s host-defense mechanisms. Therapeutic drug concentrations after the first injection are maintained for 7 days for S. intermedius infections and for 14 days for S. canis (Group G) infections. Maximum treatment should not exceed 2 injections.
Cats
Convenia should be administered as a single, one-time subcutaneous injection at a dose of 3.6 mg/lb (8 mg/kg) body weight. After an injection of Convenia, therapeutic concentrations are maintained for approximately 7 days for Pasteurella multocida infections.
General Dosing Information
A sample of the lesion should be obtained for culture and susceptibility testing prior to beginning antimicrobial therapy. Once results become available, continue with appropriate therapy. If acceptable response to treatment is not observed, or if no improvement is seen within 3 to 4 days, then the diagnosis should be re-evaluated and appropriate alternative therapy considered.
Convenia may persist in the body for up to 65 days. The effect of remaining concentrations of cefovecin on any subsequent antimicrobial therapies has not been determined. Fluoroquinolone and aminoglycoside antimicrobials have been reported to be compatible with cephalosporin antimicrobial agents.1
| Dose | 3.6 mg/lb (8 mg/kg) subcutaneous injection |
| Frequency | A single injection provides up to 14 days of treatment Occasionally, a repeat dose may be needed to ensure complete clinical resolution in dogs |
| Notes | Product is light-sensitive and should be stored in the original carton and refrigerated when not in use. |
Dosage Table
| Animal Weight | 5 lb | 10 lb | 15 lb | 20 lb | 40 lb | 80 lb |
| Convenia Volume | 0.23 ml | 0.45 ml | 0.67 ml | 0.90 ml | 1.80 ml | 3.60 ml |
Storage Directions
Store the powder and the reconstituted product in the original carton, refrigerated at 2° to 8° C (36° to 46° F). Use the entire contents of the vial within 56 days of reconstitution. PROTECT FROM LIGHT. After each use it is important to return the unused portion back to the refrigerator in the original carton. As with other cephalosporins, the color of the solution may vary from clear to amber at reconstitution and may darken over time. If stored as recommended, solution color does not adversely affect potency.
Contraindications
Convenia is contraindicated in dogs and cats with known allergy to cefovecin or to β-lactam (penicillins and cephalosporins) group antimicrobials. Anaphylaxis has been reported with the use of this product in foreign market experience. If an allergic reaction or anaphylaxis occurs, Convenia should not be administered again and appropriate therapy should be instituted. Anaphylaxis may require treatment with epinephrine and other emergency measures, including oxygen, intravenous fluids, intravenous antihistamine, corticosteroids, and airway management, as clinically indicated. Adverse reactions may require prolonged treatment due to the prolonged systemic drug clearance (65 days).
Warnings
Not for use in humans. Keep this and all drugs out of reach of children. Consult a physician in case of accidental human exposure. For subcutaneous use in dogs and cats only. Antimicrobial drugs, including penicillins and cephalosporins, can cause allergic reactions in sensitized individuals. To minimize the possibility of allergic reactions, those handling such antimicrobials, including cefovecin, are advised to avoid direct contact of the product with the skin and mucous membranes.
Precautions
Prescribing antibacterial drugs in the absence of a proven or strongly suspected bacterial infection isunlikely to provide benefit to treated animals and may increase the risk of the development of drug-resistantanimal pathogens.
Possible Side Effects
Dogs
Lethargy, Anorexia/Decreased Appetite, Vomiting, Diarrhea, Blood in Feces, Flatulence, Increased Borborygmi.
Cats
Vomiting, Diarrhea, Anorexia/Decreased Appetite, Lethargy, Hyper/Acting Strange, Inappropriate Urination.
